{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:17:06Z","timestamp":1789427826131,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.clbc.2019.04.007","type":"journal-article","created":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T11:07:05Z","timestamp":1555672025000},"page":"e556-e562","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["The Impact of Vaginal Laser Treatment for Genitourinary Syndrome of Menopause in Breast Cancer Survivors: A Systematic Review and Meta-analysis"],"prefix":"10.1016","volume":"19","author":[{"given":"Swati","family":"Jha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynda","family":"Wyld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka H.","family":"Krishnaswamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2019.04.007_bib1","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1038\/bjc.2012.366","article-title":"Projections of cancer prevalence in the United Kingdom, 2010-2040","volume":"107","author":"Maddams","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clbc.2019.04.007_bib2","first-page":"252","article-title":"Cancer treatment and survivorship statistics, 2014","volume":"64","author":"DeSantis","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clbc.2019.04.007_bib3","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.maturitas.2014.07.013","article-title":"Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society","volume":"79","author":"Portman","year":"2014","journal-title":"Maturitas"},{"key":"10.1016\/j.clbc.2019.04.007_bib4","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1056\/NEJMoa067423","article-title":"A\u00a0study of sexuality and health among older adults in the United States","volume":"357","author":"Lindau","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clbc.2019.04.007_bib5","first-page":"2133","article-title":"Prevalence and impact of vaginal symptoms among postmenopausal women","volume":"6","author":"Santoro","year":"2009","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.clbc.2019.04.007_bib6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4065\/mcp.2009.0413","article-title":"Vulvovaginal atrophy","volume":"85","author":"Mac Bride","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.clbc.2019.04.007_bib7","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3816\/CBC.2009.n.020","article-title":"Prevalence and severity of urogenital symptoms in postmenopausal women receiving endocrine therapy for breast cancer","volume":"9","author":"Chin","year":"2009","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.clbc.2019.04.007_bib8","doi-asserted-by":"crossref","first-page":"E17","DOI":"10.1188\/15.ONF.E17-E23","article-title":"Women with breast cancer: self-reported distress in early survivorship","volume":"42","author":"Lester","year":"2015","journal-title":"Oncol Nurs Forum"},{"key":"10.1016\/j.clbc.2019.04.007_bib9","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.maturitas.2010.08.001","article-title":"Women's voices in the menopause: results from an international survey on vaginal atrophy","volume":"67","author":"Nappi","year":"2010","journal-title":"Maturitas"},{"key":"10.1016\/j.clbc.2019.04.007_bib10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/13697137.2013.871696","article-title":"Impact of vulvovaginal atrophy on sexual health and quality of life at postmenopause","volume":"17","author":"Nappi","year":"2014","journal-title":"Climacteric"},{"key":"10.1016\/j.clbc.2019.04.007_bib11","first-page":"S55","article-title":"Premature menopause in young breast cancer: effects on quality of life and treatment interventions","volume":"5 Suppl 1","author":"Rosenberg","year":"2013","journal-title":"J\u00a0Thorac Dis"},{"key":"10.1016\/j.clbc.2019.04.007_bib12","first-page":"105","article-title":"Treating dyspareunia caused by vaginal atrophy: a review of treatment options using vaginal estrogen therapy","volume":"1","author":"Kingsberg","year":"2010","journal-title":"Int J Womens Health"},{"key":"10.1016\/j.clbc.2019.04.007_bib13","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1188\/09.ONF.693-698","article-title":"Urogenital atrophy in breast cancer survivors","volume":"36","author":"Lester","year":"2009","journal-title":"Oncol Nurs Forum"},{"key":"10.1016\/j.clbc.2019.04.007_bib14","first-page":"50","article-title":"Atrophic vaginitis in breast cancer survivors: a difficult survivorship issue","volume":"5","author":"Lester","year":"2015","journal-title":"J\u00a0Pers Med"},{"key":"10.1016\/j.clbc.2019.04.007_bib15","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ijwd.2016.05.003","article-title":"Vaginal rejuvenation using energy-based devices","volume":"2","author":"Karcher","year":"2016","journal-title":"Int J Womens Dermatol"},{"key":"10.1016\/j.clbc.2019.04.007_bib16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/GME.0000000000000955","article-title":"Randomized, double-blind, placebo-controlled clinical trial for evaluating the efficacy of fractional CO2 laser compared with topical estriol in the treatment of vaginal atrophy in postmenopausal women","volume":"25","author":"Cruz","year":"2018","journal-title":"Menopause"},{"key":"10.1016\/j.clbc.2019.04.007_bib17","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/GME.0000000000000401","article-title":"Histological study on the effects of microablative fractional CO2 laser on atrophic vaginal tissue: an ex\u00a0vivo study","volume":"22","author":"Salvatore","year":"2015","journal-title":"Menopause"},{"key":"10.1016\/j.clbc.2019.04.007_bib18","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1080\/13697137.2016.1212006","article-title":"The effect of microablative fractional CO2 laser on vaginal flora of postmenopausal women","volume":"19","author":"Athanasiou","year":"2016","journal-title":"Climacteric"},{"key":"10.1016\/j.clbc.2019.04.007_bib19","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1097\/GME.0000000000000839","article-title":"Use of a novel fractional CO2 laser for the treatment of genitourinary syndrome of menopause: 1-year outcomes","volume":"24","author":"Sokol","year":"2017","journal-title":"Menopause"},{"key":"10.1016\/j.clbc.2019.04.007_bib20","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.clbc.2019.04.007_bib21","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1007\/s10103-018-2471-3","article-title":"Fractional CO2 laser for genitourinary syndrome of menopause in breast cancer survivors: clinical, immunological, and microbiological aspects","volume":"33","author":"Becorpi","year":"2018","journal-title":"Lasers Med Sci"},{"key":"10.1016\/j.clbc.2019.04.007_bib22","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/GME.0000000000000761","article-title":"Vaginal erbium laser as second-generation thermotherapy for the genitourinary syndrome of menopause: a pilot study in breast cancer survivors","volume":"24","author":"Gambacciani","year":"2017","journal-title":"Menopause"},{"key":"10.1016\/j.clbc.2019.04.007_bib23","series-title":"Novel hybrid fractional Erbium Yag laser: short term outcomes for treatment of genitourinary syndrome of menopause and dyspareunia","author":"Gueretta","year":"2017"},{"key":"10.1016\/j.clbc.2019.04.007_bib24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.maturitas.2015.02.179","article-title":"A\u00a0new fractionated CO2 laser to treat vulvovaginal atrophy in breast cancer patients","volume":"81","author":"Joris","year":"2015","journal-title":"Maturitas"},{"key":"10.1016\/j.clbc.2019.04.007_bib25","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1016\/j.jmig.2015.08.269","article-title":"Microablative fractional CO2 laser for vulvovaginal atrophy in women with a history of breast cancer","volume":"22","author":"Leone Roberti Maggiore","year":"2015","journal-title":"J\u00a0Minim Invasive Gynecol"},{"key":"10.1016\/j.clbc.2019.04.007_bib26","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s00432-018-2614-8","article-title":"Ablative dual-phase Erbium:YAG laser treatment of atrophy-related vaginal symptoms in post-menopausal breast cancer survivors omitting hormonal treatment","volume":"144","author":"Mothes","year":"2018","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"10.1016\/j.clbc.2019.04.007_bib27","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/GME.0000000000001053","article-title":"Fractional microablative CO2 laser in breast cancer survivors affected by iatrogenic vulvovaginal atrophy after failure of nonestrogenic local treatments: a retrospective study","volume":"25","author":"Pagano","year":"2018","journal-title":"Menopause"},{"key":"10.1016\/j.clbc.2019.04.007_bib28","series-title":"Symptomatic improvment of vulvovaginal atrophy in breast cancer patients using vaginal laser therapy: report from LAAVA pilot study","author":"Pearson","year":"2017"},{"key":"10.1016\/j.clbc.2019.04.007_bib29","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00404-016-4118-6","article-title":"Fractional CO2 laser for vulvovaginal atrophy (VVA) dyspareunia relief in breast cancer survivors","volume":"294","author":"Pieralli","year":"2016","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.clbc.2019.04.007_bib30","series-title":"CO2 laser as a treatment option for genitourinary syndrome of menopause (GSM) in oncologogical patients: preliminary results","author":"Scibilia","year":"2017"},{"key":"10.1016\/j.clbc.2019.04.007_bib31","first-page":"1","article-title":"Closing the quality gap: revisiting the state of the science (vol. 3: quality improvement interventions to address health disparities)","author":"McPheeters","year":"2012","journal-title":"Evid Rep Technol Assess (Full Rep)"},{"key":"10.1016\/j.clbc.2019.04.007_bib32","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1080\/13697137.2018.1436538","article-title":"Long-term effects of vaginal erbium laser in the treatment of genitourinary syndrome of menopause","volume":"21","author":"Gambacciani","year":"2018","journal-title":"Climacteric"},{"key":"10.1016\/j.clbc.2019.04.007_bib33","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.maturitas.2017.06.029","article-title":"Laser therapy for the genitourinary syndrome of menopause. A systematic review and meta-analysis","volume":"103","author":"Pitsouni","year":"2017","journal-title":"Maturitas"},{"key":"10.1016\/j.clbc.2019.04.007_bib34","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.sxmr.2017.07.003","article-title":"Sexual function in women suffering from genitourinary syndrome of menopause treated with fractionated CO2 laser","volume":"5","author":"Salvatore","year":"2017","journal-title":"Sex Med Rev"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820919300783?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820919300783?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:18:32Z","timestamp":1761513512000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820919300783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S1526820919300783"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2019.04.007","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Impact of Vaginal Laser Treatment for Genitourinary Syndrome of Menopause in Breast Cancer Survivors: A Systematic Review and Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2019.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}